Clinicians can be reassured that evidence supports recommendations (eg, Global Initiative for Asthma) that pregnant women with asthma can continue use of inhaled corticosteroids (ICSs) during pregnancy, as published in JAMA Network Open. In the study of 6,105 pregnant women in South Korea, 2,108 women (34.5%) continued ICS during the first trimester and were compared to 3,997 women (65.5%) who discontinued ICS during the first trimester. Researchers found ICS continuation was not associated with significantly …
Read More
